Drug Development

Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing.

Cephalon Buys Mepha; BASi's CEO Retires; and More.

Hoping to prevent the deaths of eight million children over the next decade, Bill and Melinda Gates recently committed $10 billion for child-immunization programs in the world's poorest countries.

The author discusses how the use of a visible residue limit has made the 10-ppm cleaning limit obsolete in many applications.

Sharing too much-or too little-information can have disastrous onsequences.

As contract manufacturers and drug companies meet at Informex, the stage is set for the latest in pharmaceutical chemical development.

FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.

A recent book provides information about formulating biopharmaceuticals that is easy to swallow.

Regulators and industry move to require inspections of API manufacturing facilities.

When it comes to healthcare rform, we must not overlook investment in innovative technologies.

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods. This article contain bonus online material.

Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material.

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.

References for the article published in the February issue of Pharmaceutical Technology Europe.

Eran Gabbai, CEO and President of Do-Coop Technologies, explains the benefits of a new water-based nanotechnology.

Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.

FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility.

Could flexible manufacturing change the standards for biopharmaceutical production? To find out, Equipment and Processing Report talked to James Robinson, vice-president of technical and quality operations at biotechnology company Novavax (Rockville, MD).

The authors sought to improve the productivity of protein synthesis by using a highly active cell-free extract from Escherichia coli and by optimizing buffer conditions and shaking conditions.

The United States Pharmacopeial Convention is recalling USP 33?NF 28.

Bioject Medical Technologies establishes alliance with MPI Research; Biogen Idec CEO to retire; And More.

This study used biological indicators containing Geobacillus stearothermophilus spores and a new technology to continuously monitor incubated BIs and record nonsterile results.

Team leaders in FDA's Office of Generic Drugs provide an overview.

Plus, novel dosage forms and emerging trends.

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.